Eyeforpharma Real World Evidence Conference Round up 2018
Earlier this month, APAC Director Pei Li Teh attended Asia’s 11th Eyeforpharma conference in Tokyo, Japan with a focus on Real World Evidence (RWE)
This year has seen a turning point for Japan's pharma industry, as the government and the industry encourage a rapid move towards increased use of RWE from April 2018. Real World Data (RWD) sources provide an unprecedented opportunity for companies to find, demonstrate and communicate their real value to patients, healthcare and society. The conference included topics addressing commercial and medical needs, allowing both communities to come together for the first time encouraging collaboration across functions.
EphMRA Annual Conference 2018
Visit us on stand number 20
We are delighted to be presenting, exhibiting and sponsoring the EphMRA Annual Conference in Basel, from 26-28 June. Representing Research Partnership at the event are Senior Director Angela Duffy, Director Richard Head, and Associate Director An-hwa Lee.
Intellus round up 2018
Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia
The theme of the conference was ‘7 billion voices’, exploring how patient experiences, programs and health literacy can be improved through insights delivered by market researchers in the pharmaceutical industry.
ESOMAR Asia Pacific 2018
13-15 May, Bangkok
Research Partnership is delighted to be attending the ESOMAR conference in Bangkok 13-15 May. The theme of this years’ conference is DRIVE: Data Research Insights Vision Excellence. The event will see an assembly of a range of brands and companies to the ESOMAR Asia Pacific stage to challenge the traditional, expand new thinking and take insights to the next level within the pharmaceutical industry.
Eyeforpharma – Real World Evidence 2018
16-17 May in Tokyo, Japan
Research Partnership is delighted to be attending the Eyeforpharma Real World Evidence (RWE) conference in Tokyo, Japan 16-17 May. RWE is currently a very hot topic for the Japanese pharma industry, with an increased push to place RWE as a strategic imperative for pharma.